Khan JA

References (4)

Title : Synthesis, DFT, ADMET and molecular docking studies of thiazole derived thiazolidinone-based chalcone derivatives: alzheimer's disease current therapies - Nadeem_2024_Future.Med.Chem__1
Author(s) : Nadeem MS , Khan JA , Kazmi I , Moglad E , Afzal M , Alzarea SI , Rahim F , Khan S , Muhammad K , Gupta G
Ref : Future Med Chem , :1 , 2024
Abstract :
PubMedSearch : Nadeem_2024_Future.Med.Chem__1
PubMedID: 39628307

Title : Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A\/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies - Nadeem_2021_Int.J.Biol.Macromol_193_19
Author(s) : Nadeem MS , Khan JA , Rashid U
Ref : Int J Biol Macromol , 193 :19 , 2021
Abstract :
PubMedSearch : Nadeem_2021_Int.J.Biol.Macromol_193_19
PubMedID: 34687762

Title : Strigolactones-a novel class of phytohormones as anti-cancer agents - Hasan_2018_J.Pestic.Sci_43_168
Author(s) : Hasan MN , Razvi SSI , Kuerban A , Balamash KS , Al-Bishri WM , Abulnaja KO , Choudhry H , Khan JA , Moselhy SS , M Z , Kumosani TA , Al-Malki AL , Alhosin M , Asami T
Ref : J Pestic Sci , 43 :168 , 2018
Abstract :
PubMedSearch : Hasan_2018_J.Pestic.Sci_43_168
PubMedID: 30363122

Title : Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus - Mushtaq_2014_CNS.Neurol.Disord.Drug.Targets_13_1432
Author(s) : Mushtaq G , Greig NH , Khan JA , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :1432 , 2014
Abstract :
PubMedSearch : Mushtaq_2014_CNS.Neurol.Disord.Drug.Targets_13_1432
PubMedID: 25345511